182 A small proof-of-concept trial using fulvestrant on five PAH patients showed an increasing trend of the primary outcome 6-minute walking distance comparing baseline with 9 weeks of treatment, although not significant ( NCT02911844 ). 183 Two clinical studies are being conducted using anastrozole in PAH.
1
—
—